[新型俄罗斯制剂羟甲环素用于慢性非特异性肺部疾病患者的试验]
[A trial of the use of the new Russian preparation oxymetacil in patients with chronic nonspecific lung diseases].
作者信息
Borisova A M
出版信息
Ter Arkh. 1995;67(3):20-2.
PMID:7770795
Abstract
The trial of oxymethacyl was conducted in 20 CNSPD patients. Clinicoimmunological examinations provided evidence on the drug effectiveness as it stimulated cell immunity, phagocytosis, was well tolerated, caused no side effects. The highest response was achieved in combination of oxymethacyl with antibacterial therapy. Normalization of clinical and immunological indices in CNPD patients suggests immunocorrective effect of oxymethacyl.
摘要
对20例慢性非特异性肺部疾病（CNSPD）患者进行了羟甲环素试验。临床免疫学检查提供了该药物有效性的证据，因为它能刺激细胞免疫、吞噬作用，耐受性良好，无副作用。羟甲环素与抗菌治疗联合使用时取得了最高疗效。慢性非特异性肺部疾病（CNPD）患者临床和免疫指标的正常化表明羟甲环素具有免疫纠正作用。
相似文献
1
2
3
[Immunodiagnosis and immunotherapy of chronic nonspecific lung diseases].
Ter Arkh. 1985;57(3):62-6.
4
5
6
[Effect of adaptogenes on the immunological reactivity of patients with a history of acute pneumonia].
Vrach Delo. 1983 Feb(2):32-5.
7
[Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].[核黄素钠对丹毒抗生素治疗效果的影响]
Antibiotiki. 1984 Feb;29(2):132-5.
8
9
The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.免疫调节剂用于破坏性肺结核患者化疗的疗效
Z Erkr Atmungsorgane. 1986;167(1-2):163-7.
Zotero 插件